NOVEL VIRAL VECTOR CONSTRUCT FOR NEURON SPECIFIC CONTINUOUS DOPA SYNTHESIS IN VIVO Russian patent published in 2017 - IPC A61K48/00 C12N15/864 A61P25/16 

Abstract RU 2606012 C2

FIELD: medicine.

SUBSTANCE: inventions relate to dicistronic expression vector, its application for amelioration of Parkinson's disease, pharmaceutical composition and a method for determining the expression ratio of polypeptide of GTP-cyclohydrolase 1 and polypeptide of tyrosine hydroxylase expressed by said dicistronic vector. Presented vector contains the first top expression cassette along the transcription and the second lower expression cassette along the transcription. Said first top expression cassette along the transcription contains nucleotide sequence containing the first promoter sequence functionally connected with the first nucleotide sequence, wherein said first nucleotide sequence encodes GTP-cyclohydrolase 1 polypeptide (GCH1; EC 3.5.4.16). Said second lower expression cassette along the transcription contains nucleotide sequence containing the second promoter sequence functionally connected with the second nucleotide sequence. Said second nucleotide sequence encodes tyrosine hydroxylase polypeptide (TH; EC 1.14.16.2). At that, the vector is adeno-associated vector (AAV) and said second nucleotide sequence is functionally related to woodchuck posttranscriptional regulatory element (WPRE). Said first and second promoters are promoters of synapsin 1, the first top expression cassette along the transcription and second lower expression cassette along the transcription contain polyadenylation sequence, and expression cassettes of the dicistronic expression vector contain 5'-end repeated sequence and 3'-end repeated sequence. Polypeptides of tyrosine hydroxylase and GTP-cyclohydrolase 1 can be expressed in ratio from 3:1 to 7:1, respectively. Inventions can be used for recovery of catecholamine balance in a subject in need thereof.

EFFECT: present invention is applicable for treating disorders associated with dopamine deficiency.

21 cl, 8 dwg, 1 tbl, 3 ex

Similar patents RU2606012C2

Title Year Author Number
GENE THERAPY VECTORS FOR TREATING DANON'S DISEASE 2020
  • Keravala, Annahita
  • Prabhakar, Raj
  • Shah, Gaurav
  • Wong, Roderick
  • Yalamanchi, Naveen
  • Pratumsuwan, Piratip
RU2822925C2
VIRIONS OF AN ADENO-ASSOCIATED VIRUS WITH A VARIANT CAPSID AND METHODS FOR USING THEM 2017
  • Sheffer Devid V.
  • Klimchak Rajan R.
  • Kerber Dzhejms T.
  • Flenneri Dzhon Dzh.
  • Dalkara Mourot Deniz
  • Vizel Majke
  • Bern Lea S.T.
RU2742724C1
VIRIONS OF ADENO-ASSOCIATED VIRUS WITH OPTIONAL CAPSID AND METHODS OF THEIR USE 2012
  • Sheffer Devid V.
  • Klimchak Rajan R.
  • Kerber Dzhejms T.
  • Flenneri Dzhon Dzh.
  • Dalkara Mourot Deniz
  • Vizel Majke
  • Bern Lea S.T.
RU2611202C2
GENES AND PROTEINS FOR BIOSYNTHESIS OF LANTIBIOTIC 107891 2007
  • Donadio Stefano
  • Sosio Margerita
  • Serina Stefanija
  • Merkorillo Davide
RU2441915C9
THERAPEUTIC USE OF VEGF-C AND CCBE1 2014
  • Alitalo Kari
  • Eltsh Mikhael
  • Anisimov Andrej
RU2691104C2
INTRATHECAL ADMINISTRATION OF VECTORS BASED ON ADENO ASSOCIATED VIRUSES FOR GENE THERAPY 2016
  • Wilson James M.
  • Hinderer Christian
  • Rothwell William Thomas
RU2775138C2
CODON-OPTIMIZED NUCLEIC ACID WHICH ENCODES SMN1 PROTEIN, AND USE THEREOF 2020
  • Madera Dmitrij Aleksandrovich
  • Gershovich Pavel Mikhajlovich
  • Veselova Anna Sergeevna
  • Shugaeva Tatyana Evgenevna
  • Lomunova Mariya Andreevna
  • Shklyaeva Margarita Aleksandrovna
  • Morozov Dmitrij Valentinovich
RU2742837C1
NUCLEIC ACID MOLECULES AND WAYS OF USING THEM 2018
  • Seregin, Alexey
  • Liu, Tongyao
  • Patarroyo-White, Susannah
  • Drager, Douglas
  • Peters, Robert T.
  • Liu, Jiayun
RU2819144C2
GENE SET EXPRESSION INCLUDING sORF CONSTRUCTS AND METHODS FOR IMMUNOGLOBULIN EXPRESSION 2006
  • Karson Dzheral'D R.
  • Gion Uehndi
  • Zal'Feld Jokhen G.
  • Gu Tszitsze
  • Redzhir Din A.
  • K'Junz Jun
RU2478709C2
POLYPEPTIDE AND IMMUNE MODULATION 2014
  • Kelli Deniz
  • Patterson Andzhela
  • Monne Eduar
  • Malder Imke
RU2682651C2

RU 2 606 012 C2

Authors

Kirik Deniz

Berklund Anders

Kirik Deniz

Dates

2017-01-10Published

2010-11-09Filed